Lindsey Broussard
Dermatology · Denver, CONPI 1679006597
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.3% of the total across 312 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations.
Across 312 payments — averaging $23.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sanofi$1K
- Sun Pharmaceutical Industries Inc.$609
- UCB, Inc.$583
- Novartis$436
- Johnson & Johnson$393
- plus $3K from 19 others
What the payments were for
- Food & beverage$6,73292%
- Education$5648%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 62 | $1,294 |
| Sanofi | 30 | $1,062 |
| Sun Pharmaceutical Industries Inc. | 18 | $609 |
| UCB, Inc. | 22 | $583 |
| Novartis | 24 | $436 |
| Johnson & Johnson | 23 | $393 |
| Regeneron Healthcare Solutions, Inc. | 12 | $350 |
| Galderma Laboratories, L.p. | 11 | $308 |
| Pfizer | 13 | $299 |
| Arcutis Biotherapeutics, Inc. | 22 | $259 |
| Dermavant Sciences, Inc. | 13 | $244 |
| E.r. Squibb & Sons, L.L.C. | 13 | $236 |
| Amgen | 7 | $212 |
| Lilly USA, LLC | 4 | $180 |
| Sanofi-aventis U.S. LLC | 2 | $179 |
| Organon | 18 | $162 |
| LEO Pharma Inc. | 7 | $156 |
| Incyte Corporation | 3 | $153 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $46 |
| Organogenesis Inc. | 1 | $33 |
| Boehringer Ingelheim | 1 | $30 |
| Davol Inc. | 1 | $21 |
| Botanix SB Inc | 1 | $18 |
| Almirall LLC | 1 | $18 |
| Journey Medical Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,296 in reported general payments places this provider in the 80th percentile of 280 dermatology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $350,422 |
| Tacrolimus | 43 | $4,432 |
| Clobetasol Propionate | 45 | $2,708 |
| Fluorouracil | 28 | $2,428 |
| Triamcinolone Acetonide | 76 | $996 |
| Doxycycline Hyclate | 40 | $981 |
| Ketoconazole | 44 | $764 |
| Clindamycin Phosphate | 20 | $634 |
| Minoxidil | 26 | $453 |
| Hydrocortisone | 23 | $190 |
| Mupirocin | 20 | $128 |
| Clotrimazole | 14 | $116 |
| Finasteride | 14 | $76 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Denver
- Drew TaylorDenver$135K
- Adrienne StewartDenver$102K
- Elizabeth ShurnasDenver$13K
- Carl DemidovichDenver$13K
- Elizabeth RobinsonDenver$11K
- Caroline HaganDenver$8K
- Catherine CarreteroDenver$7K
- Channing HoodDenver$7K
- Marcjonathan SerotaLittleton$3.2M
- Ammon LarsenLoveland$620K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.